{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:26:21Z","timestamp":1789122381384,"version":"build-2803163510"},"reference-count":42,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Sci.","Medical Sciences"],"abstract":"<jats:p>Background\/Objectives: Excisional treatment is effective for cervical intraepithelial neoplasia grade 2 or 3 (CIN2\u20133), but residual or recurrent high-grade disease remains clinically important. This focused systematic review evaluated post-treatment high-risk human papillomavirus (hrHPV) testing as a test of cure and compared it with cytology and resection-margin status. Methods: PubMed\/MEDLINE was searched and supplemented by structured citation checking and targeted verification, with supplementary Embase and CENTRAL searches conducted during peer review; the review was not prospectively registered. Mixed-grade cohorts were retained only when a high-grade subgroup was extractable or for supportive qualitative evidence. Results: Fifteen primary studies enrolled 21,932 treated women, of whom 18,992 contributed to endpoint-specific analyses. Explicit CIN2+\/CIN3+\/HSIL+ event rates were 1.9\u20136.8% in most studies, with 11.8% in one earlier intensively verified cohort; higher rates in other reports reflected any-grade CIN or composite outcomes and were not treated as CIN2+. In the subset reporting directly comparable accuracy measures, hrHPV testing was generally more sensitive than cytology and negative predictive values were 98.0\u2013100%. These values require caution because recurrence prevalence was low and histological verification was incomplete in several cohorts. Five studies were judged at low, eight at unclear, and two at high overall risk of bias for their diagnostic-accuracy contributions. Conclusions: The evidence supports hrHPV-based risk stratification and reduced-intensity surveillance after a negative test, but not unqualified return to routine population screening. Standardised prospective studies with uniform CIN2+ endpoints and complete verification remain needed.<\/jats:p>","DOI":"10.3390\/medsci14050561","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:09:40Z","timestamp":1789117780000},"page":"561","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-Treatment High-Risk HPV Testing as a \u201cTest of Cure\u201d: A Systematic Review"],"prefix":"10.3390","volume":"14","author":[{"given":"Gavrila","family":"Timis","sequence":"first","affiliation":[{"name":"Doctoral School, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, Victor Babes Square 8, 400347 Cluj Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3228-7881","authenticated-orcid":false,"given":"Romeo","family":"Micu","sequence":"additional","affiliation":[{"name":"Department 2, Faculty of Nursing and Health Sciences, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7350-2472","authenticated-orcid":false,"given":"Adriana Oana","family":"Oltean","sequence":"additional","affiliation":[{"name":"Department 2, Faculty of Nursing and Health Sciences, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6106-816X","authenticated-orcid":false,"given":"Iulian","family":"Goidescu","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynaecology I, Mother and Child Department, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400006 Cluj Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Nicula","sequence":"additional","affiliation":[{"name":"Department 2, Faculty of Nursing and Health Sciences, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucian Constantin","family":"Mocan","sequence":"additional","affiliation":[{"name":"Department of Surgery, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, Croitorilor Square 19, 400006 Cluj Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijgo.13865","article-title":"Cancer of the cervix uteri: 2021 update","volume":"155","author":"Bhatla","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J. Clin. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcancer.2013.11.002","article-title":"The human papillomavirus family and its role in carcinogenesis","volume":"26","author":"Tommasino","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ijc.27577","article-title":"Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: Implications for natural history and management","volume":"132","author":"Wentzensen","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1470-2045(07)70283-8","article-title":"Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: A meta-analysis","volume":"8","author":"Sagi","year":"2007","journal-title":"Lancet Oncol."},{"key":"ref_8","first-page":"CD008587","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"8","author":"Koliopoulos","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ygyno.2005.07.033","article-title":"Clinical utility of HPV-DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidence","volume":"99","author":"Arbyn","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/ijc.25745","article-title":"Type-specific HPV genotyping improves detection of recurrent high-grade cervical neoplasia after conisation","volume":"129","author":"Heymans","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00404-023-07242-y","article-title":"Endocervical crypt involvement by high-grade cervical intraepithelial neoplasia and its association with high-grade histopathological recurrence after cervical excision in women with negative excision margins: A systematic review and meta-analysis","volume":"309","author":"Papoutsis","year":"2024","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"i3633","DOI":"10.1136\/bmj.i3633","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: Systematic review and meta-analysis","volume":"354","author":"Kyrgiou","year":"2016","journal-title":"BMJ"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0140-6736(17)31821-4","article-title":"Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16\u201326 years: A randomised, double-blind trial","volume":"390","author":"Huh","year":"2017","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ygyno.2012.01.015","article-title":"High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: A systematic review and meta-analysis","volume":"125","author":"Kocken","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S1470-2045(17)30700-3","article-title":"Incomplete excision of cervical precancer as a predictor of treatment failure: A systematic review and meta-analysis","volume":"18","author":"Arbyn","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/AOG.0000000000005997","article-title":"Prediction of Treatment Failure After Excisional Treatment of Cervical Precancer: A Systematic Review and Meta-analysis","volume":"146","author":"Bomans","year":"2025","journal-title":"Obstet. Gynecol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_18","first-page":"548","article-title":"Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia","volume":"34","author":"Du","year":"2013","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/cyt.12260","article-title":"Does LLETZ excision margin status predict residual disease in women who have undergone post-treatment cervical cytology and high-risk human papillomavirus testing?","volume":"27","author":"Palmer","year":"2016","journal-title":"Cytopathology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ygyno.2006.04.016","article-title":"Pre- and post-conization high-risk HPV testing predicts residual\/recurrent disease in patients treated for CIN 2-3","volume":"103","author":"Alonso","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1447-0756.2008.00989.x","article-title":"High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia","volume":"35","author":"Jeong","year":"2009","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejogrb.2011.11.023","article-title":"Follow-up after LLETZ: A study of 682 cases of CIN 2-CIN 3 in a single institution","volume":"161","author":"Lubrano","year":"2012","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jasc.2013.09.004","article-title":"Human papillomavirus testing and cytologic\/histopathologic test-of-cure follow-up results after excisional treatment for high-grade cervical intraepithelial neoplasia","volume":"3","author":"Zhao","year":"2014","journal-title":"J. Am. Soc. Cytopathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.7314\/APJCP.2015.16.10.4297","article-title":"Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP","volume":"16","author":"Mo","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/aogs.12960","article-title":"Follow up with HPV test and cytology as test of cure, 6 months after conization, is reliable","volume":"95","author":"Asciutto","year":"2016","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/LGT.0000000000000373","article-title":"Effect of High-Risk Human Papillomavirus but Normal Cytology at Test of Cure on Achieving Colposcopy Standards","volume":"22","author":"Kalampokas","year":"2018","journal-title":"J. Low. Genit. Tract Dis."},{"key":"ref_28","first-page":"e201810045","article-title":"Study of conizations of the cervix after five years of cervical cancer screening with co-testing","volume":"92","year":"2018","journal-title":"Rev. Esp. Salud Publica"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/1471-0528.15932","article-title":"Evaluation of the intraoperative human papillomavirus test as a marker of early cure at 12 months after electrosurgical excision procedure in women with cervical high-grade squamous intraepithelial lesion: A prospective cohort study","volume":"127","author":"Rabasa","year":"2020","journal-title":"BJOG"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/ajo.13115","article-title":"Compliance with follow-up Test of Cure and outcomes after treatment for high-grade cervical intraepithelial neoplasia in Victoria, Australia","volume":"60","author":"Tan","year":"2020","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/LGT.0000000000000693","article-title":"HPV Test as Test of Cure After Conization for CIN2+: A Nationwide Register-Based Cohort Study","volume":"26","author":"Bruhn","year":"2022","journal-title":"J. Low. Genit. Tract Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2147\/JIR.S406082","article-title":"Platelet-to-Lymphocyte Ratio as the Prognostic Factor for Recurrence\/Residual Disease in HSIL Patients After LEEP","volume":"16","author":"Huang","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3332\/ecancer.2015.528","article-title":"Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ and microinvasive carcinoma","volume":"9","author":"Costa","year":"2015","journal-title":"Ecancermedicalscience"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7150\/jca.13503","article-title":"HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions","volume":"7","author":"Mariani","year":"2016","journal-title":"J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J. Low. Genit. Tract Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/14737159.2016.1217157","article-title":"Management of high-risk HPV-positive women for detection of cervical (pre)cancer","volume":"16","author":"Luttmer","year":"2016","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_37","first-page":"839","article-title":"Clearance of oncogenic human papillomavirus infection: Effect of smoking (United States)","volume":"13","author":"Giuliano","year":"2002","journal-title":"Cancer Causes Control"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/bmj.39363.471806.BE","article-title":"Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: Population based cohort study","volume":"335","author":"Strander","year":"2007","journal-title":"BMJ"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.38663.459039.7C","article-title":"Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: Retrospective cohort study","volume":"331","author":"Kalliala","year":"2005","journal-title":"BMJ"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: Updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e070135","DOI":"10.1136\/bmj-2022-070135","article-title":"Role of human papillomavirus vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: Systematic review and meta-analysis","volume":"378","author":"Kechagias","year":"2022","journal-title":"BMJ"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ijgc-2020-001197","article-title":"Prophylactic human papillomavirus vaccination to prevent recurrence of cervical intraepithelial neoplasia: A meta-analysis","volume":"30","author":"Bartels","year":"2020","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/5\/561\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:24:22Z","timestamp":1789118662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/5\/561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["medsci14050561"],"URL":"https:\/\/doi.org\/10.3390\/medsci14050561","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}